PEPRVision: a visualization framework for pharmacoepidemiology research
American Journal of Epidemiology · 04.11.2026 · 195 (11) · 2889-2898
DOI: 10.1093/aje/kwag121 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, online erschienen am 11.06.2026. Verfasst von Yanning Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL 32611, United States. Hauptthemen laut MEDLINE: Pharmacoepidemiology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Medical chart review is commonly used in epidemiologic research to evaluate health outcomes, refine measurement algorithms, and identify potential study biases. In pharmacoepidemiology research, administrative claims and other structured healthcare databases provide longitudinal detail suitable for similar purposes but are typically presented in tabular formats that are cumbersome to interpret. This study introduces PEPRVision, a visualization framework that transforms structured longitudinal healthcare data into intuitive graphics to support patient-profile review in pharmacoepidemiology research. PEPRVision was developed based on principles of preattentive visual processing, leveraging visual attributes such as color, spatial position, shape, and length to facilitate rapid pattern recognition. We demonstrated PEPRVision using United States administrative claims data through 4 case studies: (1) evaluating a claims-based algorithm for measuring congenital hearing loss, (2) enhancing study design decisions by identifying reverse causation in a drug-safety study, (3) assessing the face validity of signals of potential teratogenicity detected through data mining for triage for advancement to causal inference studies, and (4) identifying mechanisms of inappropriate prenatal exposure to teratogenic medications to inform improvements in risk-mitigation strategies. As a complement to population-based causal inference studies, PEPRVision facilitates review of patient-level variation, enhancing the validity and clinical relevance of pharmacoepidemiology research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL 32611, United States.
- Center for Drug Evaluation and Safety, University of Florida, Gainesville, FL 32611, United States.
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States.
- Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States.
- Department of Epidemiology, University of Florida, Gainesville, FL 32611, United States.
ORCID-Profile: Yanning Wang
Förderung
- NICHD NIH HHS
- National Institute of Child Health and Human Development
Zitieren
APA
Wang, Y., Chen, H. K., Wen, W., Cole, D. V., Maro, J. C., Rosales, A. N., Rasmussen, S. A., & Winterstein, A. G. (2026). PEPRVision: a visualization framework for pharmacoepidemiology research. American Journal of Epidemiology, 195(11), 2889-2898. https://doi.org/10.1093/aje/kwag121
Vancouver
Wang Y, Chen HK, Wen W, Cole DV, Maro JC, Rosales AN, et al. PEPRVision: a visualization framework for pharmacoepidemiology research. American Journal of Epidemiology. 2026;195(11):2889-2898. doi:10.1093/aje/kwag121
BibTeX
@article{Wang2026,
author = {Wang, Yanning and Chen, Hung-Kai and Wen, Wen and Cole, David V and Maro, Judith C and Rosales, Arthur N and Rasmussen, Sonja A and Winterstein, Almut G},
title = {PEPRVision: a visualization framework for pharmacoepidemiology research},
journal = {American Journal of Epidemiology},
year = {2026},
volume = {195},
number = {11},
pages = {2889--2898},
doi = {10.1093/aje/kwag121}
}
EUVIMED